oxetorone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 2019 | 26020-55-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
treatment of migraine; RN given refers to parent cpd; structure
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Polycythaemia | 66.28 | 55.68 | 10 | 165 | 2274 | 79741939 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | N02CX06 | NERVOUS SYSTEM ANALGESICS ANTIMIGRAINE PREPARATIONS Other antimigraine preparations |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Migraine | indication | 37796009 | DOID:6364 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.48 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D05290 | KEGG_DRUG |
| 34522-46-8 | SECONDARY_CAS_RN |
| C0069760 | UMLSCUI |
| CHEBI:135364 | CHEBI |
| CHEMBL3989752 | ChEMBL_ID |
| CHEMBL3989638 | ChEMBL_ID |
| DB13463 | DRUGBANK_ID |
| C011962 | MESH_SUPPLEMENTAL_RECORD_UI |
| 36846 | PUBCHEM_CID |
| 2840 | INN_ID |
| T3XOS33TIQ | UNII |
| 32633 | RXNORM |
| 005618 | NDDF |
| 005619 | NDDF |
Pharmaceutical products:
None